Skip to main content


  • AddRemove
  • Build a Report 
Media Coverage

Q&A: Mayer Brown's Brian Nolan on strategy behind drug patent challenges

29 April 2015
Reuters (subscription required)
In this Q&A interview, Intellectual Property partner Brian Nolan (New York) discusses strategy behind drug patent challenges.

The Build a Report feature requires the use of cookies to function properly.  Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently.  If you do not accept cookies, this function will not work.  For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.